Compare CTMX & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTMX | EVTL |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 607.7M |
| IPO Year | 2015 | N/A |
| Metric | CTMX | EVTL |
|---|---|---|
| Price | $4.84 | $3.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $8.86 | ★ $13.20 |
| AVG Volume (30 Days) | ★ 2.5M | 786.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $138,103,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.58 | ★ N/A |
| Revenue Growth | ★ 36.45 | N/A |
| 52 Week Low | $0.40 | $2.76 |
| 52 Week High | $6.35 | $7.60 |
| Indicator | CTMX | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 37.32 |
| Support Level | $3.83 | $3.71 |
| Resistance Level | $6.20 | $4.70 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 16.01 | 11.46 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.